Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Mar 7, 2024
- Accession no.
- 0001415889-24-007191
- Filed
- Mar 7, 2024
- Trade date
- Mar 7, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.42M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Common Stock | MOption exerciseAcquired | +6,000 | $117.76 | +$706,560 | 42,599 | Direct | |
| Mar 7, 2024 | Common Stock | SSaleDisposed | −3,000 | $236.90F2 | −$710,700 | 39,599 | Direct | |
| Mar 7, 2024 | Common Stock | SSaleDisposed | −2,700 | $237.76F3 | −$641,952 | 36,899 | Direct | |
| Mar 7, 2024 | Common Stock | SSaleDisposed | −300 | $238.85 | −$71,655 | 36,599 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 60,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $236.34 to $237.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $237.34 to $238.175. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.